# NEVIRAPINE
> **ANDA205921** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2014-08-26
## Drug
- **FDA Application Number:** ANDA205921
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NEVIRAPINE
- **Generic name:** Nevirapine
- **Active ingredients:** NEVIRAPINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN LABS LTD
- **First approval:** 2014-08-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205921)
---
*MORVS · CC0 1.0*